Quick Answer
Revium Rx. reported Diluted EPS of $0.22 per share (loss) for fiscal year 2025.
Revium Rx. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.22 | — |
- The most recent figure is from Revium Rx.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: